Bitvio 0.1% Cream

Bitvio 0.1% Cream is a topical corticosteroid preparation containing mometasone furoate, used to treat inflammatory skin conditions such as eczema (atopic dermatitis), psoriasis, contact dermatitis, and other steroid-responsive skin disorders. The cream base is lighter and less greasy than an ointment, making it well suited to weeping, moist, or exuding lesions, larger body surface areas, and skin folds where a heavier ointment may feel uncomfortable or trap excess moisture. It works by reducing redness, swelling, itching, and inflammation, helping the affected skin settle and heal.

Because mometasone furoate is a potent topical corticosteroid, Bitvio 0.1% Cream is classified as a prescription-only medicine in Malaysia and Singapore. A doctor’s assessment through an online consultation with DoctorOnCall is required before this product is dispensed, so the type, location, and severity of the skin condition can be properly evaluated, ensuring the cream is appropriate and that treatment duration is limited to reduce the risk of steroid-related skin side effects.

Mometasone furoate is a synthetic corticosteroid that works by binding to glucocorticoid receptors within skin cells, which suppresses the release of inflammatory chemical mediators and reduces the activity of immune cells involved in the inflammatory response. This action decreases redness, swelling, itching, and the abnormal skin cell turnover seen in conditions such as psoriasis, providing relief from both the appearance and discomfort of the affected skin, with the cream base allowing the medicine to spread easily over larger or moist areas.

Bitvio 0.1% Cream should be used only as directed by the doctor consulted through DoctorOnCall. A thin layer is typically applied to the affected skin once daily, gently rubbed in until absorbed, and hands should be washed afterward unless the hands are the area being treated. It should not be applied under airtight dressings or bandages unless specifically instructed, as this significantly increases absorption and the risk of side effects.

The dosage, application frequency, and duration of Bitvio 0.1% Cream must be determined by the prescribing doctor based on the specific skin condition, its location, and severity. Treatment is generally limited to a short course, and continuous use, especially on the face, groin, or in children, is typically avoided or closely monitored due to the increased risk of skin thinning and other steroid-related effects with prolonged application.

Bitvio 0.1% Cream is generally stable for up to 24 to 36 months from the date of manufacture when the tube remains unopened and is stored correctly; the specific expiry date is printed on the tube and carton. The cream should not be used past its labelled expiry date, and leftover product from a previous prescription should be checked with a pharmacist before reuse.

Store Bitvio 0.1% Cream at room temperature, below 30 degrees Celsius, in a cool, dry place away from direct sunlight. Keep the tube tightly closed after each use, and store out of reach and sight of children and pets.

• Known hypersensitivity or allergy to mometasone furoate or any other ingredient in the cream
• Untreated bacterial, viral, or fungal skin infections at the application site
• Chickenpox, shingles, or other primary viral skin lesions
• Rosacea, perioral dermatitis, or acne vulgaris, which can be worsened by topical corticosteroids
• Use on the face, groin, or armpits for prolonged periods without close medical supervision
• Not recommended for use in the eyes or on mucous membranes

• Avoid using other topical corticosteroid products at the same time without medical advice, as this may increase the overall steroid load and risk of side effects
• Use of occlusive dressings alongside this cream can significantly increase systemic absorption and side effects
• Inform the prescribing doctor of any other topical treatments, including traditional or herbal remedies, applied to the same area
• No significant food interactions are expected with topical use, as systemic absorption is normally minimal when used as directed

• Complete the DoctorOnCall online consultation so the doctor can confirm this treatment is appropriate for your specific skin condition
• Apply only a thin layer to the affected area and avoid healthy surrounding skin
• Do not use for longer than the prescribed duration, even if the skin appears to have improved
• Avoid covering the treated area with airtight dressings unless specifically instructed
• Follow up with your doctor if the condition does not improve as expected or if it worsens
• Choose this cream over the ointment variant if your doctor advises it for moist, weeping, or larger-area lesions where a lighter texture is preferred

Bitvio 0.1% Cream is intended for short-term, doctor-supervised treatment of specific inflammatory skin conditions and should not be used as a general moisturiser or for undiagnosed skin complaints. Because it is a potent corticosteroid, ongoing medical supervision helps to balance effective symptom control against the risk of skin thinning and other steroid-related side effects with prolonged use. Customers in Malaysia and Singapore can obtain this medicine through DoctorOnCall after an online consultation confirms it is medically appropriate, and the doctor can also advise whether the cream or the ointment form of Bitvio 0.1% is better suited to a particular lesion.